Neuronetics (STIM) EBITDA Yield: History & Chart

Neuronetics, Inc.(STIM)

Medical - Devices · Malvern, PA

$2.21+0.01 (+0.45%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Neuronetics, Inc.

Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.

Malvern, PA

658 employees

www.neurostar.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Daniel L. Reuvers

View full financials

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Neuronetics, Inc. (STIM)	$153.79M	N/A	N/A	N/A	N/A
Jyong Biotech Ltd. Ordinary Shares (MENS)vs ›	$153.58M	N/A	N/A	N/A	N/A
Veraxa Biotech Holding AG (VRXA)vs ›	$152.72M	N/A	N/A	N/A	N/A
Inogen, Inc. (INGN)vs ›	$156.22M	N/A	4.75%	3.30%	2.87%
Cardiol Therapeutics Inc. (CRDL)vs ›	$151.01M	N/A	N/A	N/A	N/A
ALX Oncology Holdings Inc. (ALXO)vs ›	$149.36M	N/A	N/A	N/A	N/A
Korsana Biosciences, Inc. (KRSA)vs ›	$148.73M	N/A	N/A	N/A	N/A
Voyager Therapeutics, Inc. (VYGR)vs ›	$148.64M	N/A	17.25%	38.66%	34.07%
Coherus Oncology, Inc. (CHRS)vs ›	$159.14M	N/A	12.03%	9.31%	9.31%
LifeMD, Inc. (LFMDP)vs ›	$159.22M	N/A	0.81%	0.81%	0.81%

NAME

MARKET CAP

EBITDA YIELD

TTM

Neuronetics, Inc. (STIM)

$153.79M

N/A

Jyong Biotech Ltd. Ordinary Shares (MENS)vs ›

$153.58M

N/A

Veraxa Biotech Holding AG (VRXA)vs ›

$152.72M

N/A

Inogen, Inc. (INGN)vs ›

$156.22M

N/A

4.75%

3.30%

2.87%

Cardiol Therapeutics Inc. (CRDL)vs ›

$151.01M

N/A

ALX Oncology Holdings Inc. (ALXO)vs ›

$149.36M

N/A

Korsana Biosciences, Inc. (KRSA)vs ›

$148.73M

N/A

Voyager Therapeutics, Inc. (VYGR)vs ›

$148.64M

N/A

17.25%

38.66%

34.07%

Coherus Oncology, Inc. (CHRS)vs ›

$159.14M

N/A

12.03%

9.31%

LifeMD, Inc. (LFMDP)vs ›

$159.22M

N/A

0.81%

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

EBITDA Yield: N/A

STIM EBITDA Yield Metrics

STIM Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics